Evidence map›Paper›PMID 37777747›Full record

SynthesisBMC pregnancy and childbirth2023

Impact of maternal psoriasis on adverse maternal and neonatal outcomes: a systematic review and meta-analysis.

Shoboo Rahmati, Hossein Moameri, Neda Malek Mohammadi, Mojtaba Norouzi, Nima Ghalekhani, Amin Beigzadeh, Nasrin Changizi, Hamid Sharifi

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC pregnancy and childbirth, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Pruritus in Pregnancy.Journal of obstetrics and gynaecology of India · 2024
    Review
  6. Pregnancy Outcomes in Hidradenitis Suppurativa Patients.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shoboo RahmatiDepartment of Epidemiology and Biostatistics, Faculty of Public Health, Kerman University Of Medical Sciences, Kerman, Iran.
Hossein MoameriDepartment of Epidemiology and Biostatistics, Faculty of Public Health, Kerman University Of Medical Sciences, Kerman, Iran.
Neda Malek MohammadiDepartment of Epidemiology and Biostatistics, Faculty of Public Health, Kerman University Of Medical Sciences, Kerman, Iran.
Mojtaba NorouziDepartment of Epidemiology and Biostatistics, Faculty of Public Health, Kerman University Of Medical Sciences, Kerman, Iran.
Nima GhalekhaniHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Amin BeigzadehEducation Development Center, Sirjan School of Medical Sciences, Sirjan, Iran.
Nasrin ChangiziMaternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hamid SharifiHIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. sharifihami@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a dearth of robust evidence regarding the correlation between psoriasis with maternal and neonatal outcomes, making it challenging to establish definitive recommendations for the management of these patients. This systematic review and meta-analysis aimed to review the evidence with regard to the impact of maternal psoriasis on maternal and neonatal outcomes.

methodsFollowing the PRISMA guideline, a systematic search of English articles using PubMed, Embase, Scopus, ScienceDirect, Web of Science, Google Scholar, and the Cochrane Library was conducted. The search was performed from inception to 22

resultA significant association was observed between psoriasis and maternal outcomes, including cesarean delivery [OR = 1.25 (95% CI: 1.13-1.30, p-value = 0.001)], (pre)eclampsia [OR = 1.29 (95% CI: 1.15-1.44, p-value = 0.0001)], gestational diabetes [Odds Ratio (OR) = 1.23 (95% Confidence Intervals (CI): 1.15-1.30, p-value = 0.001)], gestational hypertension [OR = 1.31 (95% CI: 1.18-1.45, p-value = 0.001)] and preterm birth [OR = 1.22 (95% CI: 1.10-1.35, p-value = 0.001)]. Also, there was a significant association between psoriasis and neonatal outcomes, including small for gestational age [OR = 1.07 (95% CI: 1.02-1.11, p-value = 0.053)], low birth weight [OR = 1.19 (95% CI: 1.02-1.38, p-value = 0.001)] and stillbirth [OR = 1.27 (95% CI: 1.04-1.55, p-value = 0.023)].

conclusionMaternal psoriasis could negatively impact maternal and neonatal outcomes. Our results strengthen the importance of close monitoring of the mothers' psoriasis status before and during pregnancy.

Indexed as

Diabetes, GestationalPre-EclampsiaPremature BirthFemaleHumansInfant, NewbornPregnancyPregnancy OutcomeStillbirthMaternal outcomesMeta-analysisNeonatal outcomesPsoriasisPsoriatic arthritis

Identifiers

PMID37777747
PMCPMC10543305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.